Inaccuracies found in key studies for blockbuster heart drug ticagrelor

In a follow-up investigation into the multibillion-dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in key platelet studies used in its FDA approval.
👉 Full Story

Hear the rainbow | Science News
- Trump's National Guard Order Is Not a Danger to America, but Hyperpolitical Generals and Admirals Are
- Steam adds more accessibility features - Anna Washenko
- Should You Repair or Replace Your Old Car? 5 Steps to Help You Decide - and
- Iran Rejects Negotiations Unless Israel Ceases Fire
- Is Kale Actually Good for You? 5 Benefits You Should Know - Lauren Manaker MS, RDN, LD
- Grand Theft Auto Trilogy Joins Netflix's Gaming Roster - Michael A. Medeiros

The McRecession - Has Fast Food Cooked Itself?
- Understanding How Anxiety Can Lead to Weight Loss - Brittany Dube, MPH
- What To Know About Anal Skin Tags - Sarah Bradley
- Democrats Are Suddenly Anti-Mask
- Jake Tapper Still Working the Weasel Words
- Award-Winning War Movie Is Dominating Netflix - Jonathan Klotz
- With Masters of the Universe Wrapped and Voltron Powering Up, It’s Time for Thundercats to Roar - Staff